Results 101 to 110 of about 16,174 (186)

Derivation and external validation of a venous thromboembolism risk prediction model in asparaginase-treated ALL. [PDF]

Blood Adv
Anderson DR, Gangaraju R, Sedhom WG, Hamulyák EN, Wang TF, O'Dwyer K, Carney BJ, Muthiah C, Liedtke M, Badar T, Shimony S, Robinson R, Sanfilippo K, Derkach A, Dinner S, Biemond BJ, Nemirovsky D, Goldberg LA, Kapadia AD, Levavi H, Bar-Natan M, Van Hyfte G, Bansal K, Carrier M, Fulcher J, Gerrits AM, Litzow MR, Luger S, Guru Murthy GS, Luskin M, Wolach O, Shomali W, Zwicker JI, Stock W, Leader A.   +34 more
europepmc   +1 more source

Trends in Comorbidity for Patients with Venous Thromboembolism in a General Hospital: 2018 to 2022. [PDF]

Clin Pract
Jiménez Reyes L, Jareño Esteban JJ, Fernández Bermejo LA, Gutiérrez Ortega C, de Miguel-Díez J.   +4 more
europepmc   +1 more source

Venous thromboembolism risk assessment and prophylaxis in cancer patients. [PDF]

BMC Cancer
Nebhnani K, Muhammad Soomar S, Rana S.
europepmc   +1 more source

Safety and effectiveness of rivaroxaban thromboprophylaxis in adrenocorticotropic hormone-dependent Cushing syndrome.

J Clin Endocrinol Metab
Htut Z, Mundhra A, Lazarus K, Martin N, Papadopoulou D, Meeran K, Wernig F.   +6 more
europepmc   +1 more source

Anticoagulation challenges in cancer patients: prevention, detection, and treatment strategies. [PDF]

Cardiooncology
Chiusolo S, Kriesberg C, Oligino E, Guha A, Abdel-Qadir H, Carver J, Casselli S, Lenihan D.   +7 more
europepmc   +1 more source

The dilemma of thromboprophylaxis in stroke patients. [PDF]

Clin Med (Lond)
Guru S, Parry-Jones A, Thachil J, Swan D.   +3 more
europepmc   +1 more source

Pharmacologic Thromboprophylaxis in Medical Inpatients: A Systematic Review and Network Meta-Analysis.

JAMA Netw Open
Marti C, Righini M, Le Gal G, Girardi L, Robert-Ebadi H, Combescure C, Reny JL, Blondon M.   +7 more
europepmc   +1 more source

Comparison of aspirin and rivaroxaban for the prevention of pulmonary embolism and deep vein thrombosis in high thrombotic risk patients with systemic lupus erythematosus: study protocol for a multicentre, prospective, randomised controlled trial. [PDF]

Lupus Sci Med
Zhang Z, Li F, Li Y, Xie Z, Du J, Mao N, Li S, Liu Y, Ge Y, Wang J, Tang Q, Kang J, Peng X, Cheng W, Li Y, Xu P, Xiao Y, Tu T, Xie X, Liu Q.   +19 more
europepmc   +1 more source

Thromboprophylaxis in multiple myeloma

Research and Practice in Thrombosis and Haemostasis
openaire   +3 more sources